# Contact | TB-500 Research Digest

> Contact the editorial team behind this TB-500 research digest. For corrections and citation questions about the thymosin beta-4 literature. Not a clinic and not a vendor.

For corrections, citation questions, and source suggestions on the TB-500 and thymosin beta-4 literature.

## Reaching the editorial desk

This is the contact page for the TB-500 research digest. The most useful messages we receive are corrections, citation questions, and pointers to peer-reviewed studies we have missed — especially anything that sharpens the line between the TB-500 fragment and full-length thymosin beta-4, or updates the regulatory status. If you have spotted an error in how a study is summarized, tell us which numbered citation and what is wrong, and we will check it against the source.

We cannot answer requests this site is not built to handle. We do not provide medical or legal advice, we do not recommend or supply any substance, and we do not discuss where to obtain anything. Messages asking for sourcing, pricing, dosing protocols, or a clinical consultation will not receive a reply, because none of those is something this editorial project does.

## What to include

A clear, specific message helps. Use the form to tell us the page, the claim or citation number, and the issue. If you are suggesting a source, a DOI or PubMed link is ideal. We read everything, prioritize corrections, and update the digest when the literature or the regulatory record changes.

---

A fiduciary-grade reading of the TB-500 and thymosin beta-4 record — each finding weighed against its own study and graded for evidence, the fragment-versus-protein line drawn in plain sight, with no clinic, pharmacy, or prescription behind the desk and nothing here dispensed or for sale.